Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Radiology Open|August 5, 2016
Diffusion-weighted MR imaging of non-complicated hepatic cysts: Value of 3T computed diffusion-weighted imagingYuko Nakamura, Toru Higaki, Yuji Akiyama, et al.
Japanese Journal of Radiology|December 6, 2022
Understanding CT imaging findings based on the underlying pathophysiology in patients with small bowel ischemiaYuko Nakamura, Shota Kondo, Keigo Narita, et al.
Cardiovascular and Interventional Radiology|November 5, 2017
Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular CarcinomaTomoyo Fuji, Yuko Nakamura, Wataru Fukumoto, et al.
Molecular Oncology|February 11, 2022
microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1Motoki Tamai, Shuichi Tatarano, Shunsuke Okamura, et al.
Biochemical and Biophysical Research Communications|September 23, 2022
Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinomaHirofumi Yoshino, Shuichi Tatarano, Motoki Tamai, et al.
Japanese Journal of Radiology|September 12, 2013
Non-occlusive mesenteric ischemia (NOMI): utility of measuring the diameters of the superior mesenteric artery and superior mesenteric vein at multidetector CTYuko Nakamura, Masaki Urashima, Naoyuki Toyota, et al.
Cancer Science|August 6, 2023
Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinomaWataru Fukumoto, Hirofumi Yoshino, Shin-Ichi Horike, et al.
BMC Cancer|October 30, 2024
Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplificationWataru Fukumoto, Shunsuke Okamura, Motoki Tamai, et al.
Frontiers in Immunology|September 1, 2022
Four cases of cytokine storm after COVID-19 vaccination: Case reportKazuhiro Murata, Naoki Nakao, Naoki Ishiuchi, et al.
Molecular Oncology|June 14, 2024
Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant modelsIchiro Kawahara, Hirofumi Yoshino, Wataru Fukumoto, et al.
Pageof 6